Two Sigma Securities’s Aravive, Inc. Common Stock ARAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-167,042
Closed -$20.7K – 3865
2023
Q4
$20.7K Sell
167,042
-115,508
-41% -$15.8K ﹤0.01% 2720
2023
Q3
$37.3K Buy
+282,550
New +$178K ﹤0.01% 2504
2022
Q1
– Sell
-12,551
Closed -$27K – 2636
2021
Q4
$27K Buy
+12,551
New +$41.7K ﹤0.01% 1377
2018
Q3
– Sell
-2,694
Closed -$33K – 3128
2018
Q2
$33K Buy
+2,694
New +$27.7K ﹤0.01% 2538
2017
Q4
– Sell
-4,727
Closed -$69K – 2077
2017
Q3
$69K Buy
+4,727
New +$477K 0.01% 708

Other funds holding ARAV

Two Sigma Securities's ARAV Position: Q1 2024 in Review

Two Sigma Securities sold out of Aravive, Inc. Common Stock (ARAV) in Q1 2024, closing a stake of 167,042 shares — an estimated $20.7K sold.

Two Sigma Securities first reported a position in ARAV in Q3 2017 and held it in 5 quarters. The position peaked at $69K in Q3 2017. 3 funds tracked by Wall St. Rank hold ARAV as of Q1 2024.

  • Two Sigma Securities reported no remaining Aravive, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Two Sigma Securities sold 167,042 Aravive, Inc. Common Stock shares in Q1 2024, an estimated $20.7K.
  • Two Sigma Securities first reported a position in Aravive, Inc. Common Stock in Q3 2017 and held it in 5 quarters.
  • Two Sigma Securities's Aravive, Inc. Common Stock position peaked at $69K in Q3 2017.
  • 3 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q1 2024.

Based on Two Sigma Securities's 13F filing for Q1 2024, filed 15 May 2024.